One-third of 97 patients with incurable blood cancer became tumor-free after immunotherapy and remain healthy after five years. The treatment uses the patient's own white blood cells that are modified to attack the cancer. The cost is much lower than traditional medications.
Patients who developed an immune response from the personalized cancer vaccine have not yet experienced recurrence after more than three years of follow-up. The vaccine creates T cells that can live for up to 100 years and retain their ability to identify and fight cancer cells.
Patients who received a personalized cancer vaccine and developed an immune response lived longer without relapse. The T-cells created by the vaccine remained in the body for about 3 years and continued to fight cancer cells.
Childhood cancer mortality in the US has decreased six-fold since the 1950s. Improved treatment methods for leukemia have led to significantly more children surviving the disease. Mortality has decreased significantly for all types of cancer, including lymphoma and multiple myeloma.
Unlike most other cancers, cervical cancer can be prevented and completely eliminated using existing tools. Several high-income countries are close to elimination, with fewer than four cases per 100,000 women.
Cervical cancer deaths among women under 25 have decreased by 60 percent between 2016-2021 in the USA. A study shows zero cases of cervical cancer among women who were vaccinated against HPV at age 12-13.
The risk of malignant melanoma is decreasing for people under 50 in Sweden since 2015. Improved awareness of sun protection and reduced access to tanning beds contribute to the decrease. Mortality from skin cancer has also decreased for age groups up to 59 years.